184 related articles for article (PubMed ID: 6769029)
1. [Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
Bolte HD
MMW Munch Med Wochenschr; 1980 Apr; 122(14):507-8. PubMed ID: 6769029
[No Abstract] [Full Text] [Related]
2. [Sulfinpyrazone in the prevention of sudden death after myocardial infarction (author's transl)].
Sherry S
MMW Munch Med Wochenschr; 1980 Apr; 122(14):517-24. PubMed ID: 6769032
[TBL] [Abstract][Full Text] [Related]
3. The anturane reinfarction trial.
Sherry S
Circulation; 1980 Dec; 62(6 Pt 2):V73-8. PubMed ID: 7438382
[TBL] [Abstract][Full Text] [Related]
4. [The Anturan reinfarct study].
Sherry S
Wien Med Wochenschr Suppl; 1980; 61():17-22. PubMed ID: 6930766
[No Abstract] [Full Text] [Related]
5. [Effects of sulfinpyrazone on early ventricular fibrillation and 2d-phase arrhythmias in acute myocardial infarction (author's transl)].
Gülker H; Bender F; Thale J; Heuer H; Kristek J; Dorsel T; Pierchalla P
Z Kardiol; 1980 Nov; 69(11):751-6. PubMed ID: 7467658
[TBL] [Abstract][Full Text] [Related]
6. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
Rühle H
Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541
[No Abstract] [Full Text] [Related]
7. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial.
Anturane Reinfarction Trial Research Group
N Engl J Med; 1978 Feb; 298(6):289-95. PubMed ID: 340942
[TBL] [Abstract][Full Text] [Related]
8. [Sulfinpyrazone in the prevention of sudden cardiac death after myocardial infarct].
Foz M
Med Clin (Barc); 1980 Jun; 75(1):32-4. PubMed ID: 7392709
[No Abstract] [Full Text] [Related]
9. Drug reduces incidence of sudden cardiac death.
Am Fam Physician; 1980 Apr; 21(4):179, 182. PubMed ID: 7377063
[No Abstract] [Full Text] [Related]
10. The Anturane reinfarction trial.
Sherry S
Thromb Haemost; 1979 Feb; 41(1):197-201. PubMed ID: 483231
[No Abstract] [Full Text] [Related]
11. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
Thiele R
Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
[No Abstract] [Full Text] [Related]
12. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
Verdecchia P
G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
[No Abstract] [Full Text] [Related]
13. Antiplatelet drugs after myocardial infarction.
Med Lett Drugs Ther; 1980 Mar; 22(6):25-6. PubMed ID: 7360108
[No Abstract] [Full Text] [Related]
14. The anturane reinfarction trial.
Shepard DS; Zeckhauser RJ
N Engl J Med; 1980 Jul; 303(1):49. PubMed ID: 6990265
[No Abstract] [Full Text] [Related]
15. The anturane reinfarction trial.
Schiff AA
N Engl J Med; 1980 Jul; 303(1):48. PubMed ID: 6990263
[No Abstract] [Full Text] [Related]
16. Platelets and prostaglandins in sudden death: therapeutic implications.
Gelman JS; Mehta J
Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
[No Abstract] [Full Text] [Related]
17. The anturane reinfarction trial.
Rothlin M
N Engl J Med; 1980 Jul; 303(1):48. PubMed ID: 6103510
[No Abstract] [Full Text] [Related]
18. Platelet aggregation and atherosclerosis.
Valladares BK; Lemberg L
Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
[TBL] [Abstract][Full Text] [Related]
19. Sulfinpyrazone decreases epinephrine-induced platelet aggregation after myocardial infarction.
Latour JG; Theroux P; Bourassa MG
Am J Cardiol; 1982 Nov; 50(5):938-44. PubMed ID: 6753559
[TBL] [Abstract][Full Text] [Related]
20. The anturane reinfarction trial.
Cowan JC; Williams EM
N Engl J Med; 1980 Jul; 303(1):48-9. PubMed ID: 7374739
[No Abstract] [Full Text] [Related]
[Next] [New Search]
